Ability of a first-pass pharmacokinetic model to characterize cyclosporine blood concentrations after administrations of sandimmune or neoral formulations

Therapeutic Drug Monitoring

Volumn 20, Issue 2, 1998, Pages 165-171

  Ducharme, Murray P ^a   Verret, Lucie ^a,b   Brouillette, Denis ^a,b   Sirois, Gérard ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MONTREAL HEART INSTITUTE   (Canada)

Author keywords

Cyclosporine; First pass; Pharmacokinetics

Indexed keywords

CYCLOSPORIN;

ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; DATA ANALYSIS; DOSE RESPONSE; DRUG ELIMINATION; DRUG FORMULATION; FIRST PASS EFFECT; HEART TRANSPLANTATION; HUMAN; PRIORITY JOURNAL; STEADY STATE;

ABSORPTION; ADMINISTRATION, ORAL; BAYES THEOREM; CHEMISTRY, PHARMACEUTICAL; CYCLOSPORINE; DRUG MONITORING; FLUORESCENCE POLARIZATION; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MODELS, BIOLOGICAL; MODELS, STATISTICAL;

EID: 0031957498     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-199804000-00006     Document Type: Article

References (11)

1. Kronbach T, Fischer V, Meyer UA. Cyclosporin metabolism in human liver: identification of a cytochrome P-450 III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs. Clin Pharmacol Ther 1988; 43:630-5.
2. Kolars JC, Awni WM, Merion RM, Watkins PB. First pass metabolism of cyclosporin by the gut. Lancer 1991;338:1488-90.
3. Ducharme MP, Warbasse LH, Edwards DJ. Disposition of intravenous and oral cyclosporine after administration with grapefruit juice. Clin Pharmacol Ther 1995;57:485-91.
4. Kovarik JM, Mueller EA, Van Bree JB, Arns W, Renner E, Kutz K. Within-day consistency in cyclosporine pharmacokinetics from a microemulsion formulation in renal transplant patients. Ther Drug Monit 1994;16:232-7.
5. Trull AK, Tan KKC, Uttridge J, Bauer T, Alexander GJ, Jamieson NV. Cyclosporin absorption from microemulsion formulation in liver transplant recipient. Lancet 1993;341:433.
6. Gibaldi M, Perrier D. Pharmacokinetics. 2nd ed. NY: Marcel Dekker, 1982.
7. Wagner JG. Pharmacokinetics for the Pharmaceutical Scientist. Lancaster: Technomic Publishing Company, 1993:59-62.
8. D'Argenio DZ, Schumitzky A. ADAPT-II User's Guide. LA: Biomedical Simulations Resource, University of Southern California, 1992.
9. Gupta SK, Legg B, Solomon LR, Johnson RWG, Rowland M. Pharmacokinetics of cyclosporin: influence of rate of constant intravenous infusion in renal transplant patients. Br J Clin Pharmacol 1987;24:519-26.
10. Fahr A. Cyclosporin clinical pharmacokinetics. Clin Pharmacokinet 1993;24:472-95.
11. Kovarik JM, Vernillet L, Mueller EA, Freiburghaus R, Niederberger W, Kutz K. Cyclosporine disposition and metabolite profiles in renal transplant patients receiving a microemulsion formulation. Ther Drug Monit 1994;16:519-25.